HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Acellular Vaccines

Vaccines that are produced by using only the antigenic part of the disease causing organism. They often require a "booster" every few years to maintain their effectiveness.
Also Known As:
Vaccines, Acellular
Networked: 124 relevant articles (13 outcomes, 13 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Locht, Camille: 4 articles (11/2012 - 05/2006)
2. Edwards, Kathryn M: 3 articles (08/2015 - 04/2014)
3. Guiso, Nicole: 3 articles (01/2015 - 11/2005)
4. Halperin, Scott A: 3 articles (01/2014 - 01/2011)
5. Axelsson, Inge: 3 articles (01/2014 - 01/2011)
6. Zhang, Linjie: 3 articles (01/2014 - 01/2011)
7. Octavia, Sophie: 2 articles (11/2015 - 01/2014)
8. Lan, Ruiting: 2 articles (11/2015 - 01/2014)
9. Sintchenko, Vitali: 2 articles (11/2015 - 01/2014)
10. Hallander, Hans O: 2 articles (01/2015 - 02/2007)

Related Diseases

1. Whooping Cough (Pertussis)
2. Infection
3. Tetanus
01/01/1997 - "Despite significantly lower tetanus potencies of the acellular vaccines in laboratory tests, no differences were found in tetanus anti-toxin responses in children."
03/01/1992 - "Whereas control of pertussis in the United States may be further improved through increased levels of diphtheria-tetanus-pertussis vaccination among eligible infants and children, the use of acellular vaccines in adolescents and adults may also be needed to reduce the burden of pertussis in very young infants."
12/01/2005 - "Acellular vaccines against diphtheria-tetanus-pertussis (acellular pertussis) (DTaP) are being progressively introduced into vaccination programs worldwide, with the aim of reducing T-helper 1 (Th1)-associated reactogenicity associated with the cellular diphtheria-tetanus-pertussis (whole-cell pertussis) (DTwP) vaccine. "
02/01/2000 - " (5) In the absence of direct comparisons with the cellular pertussis vaccine available in France in tetravalent or pentavalent vaccines, indirect evidence and data from a trial comparing the acellular two-component vaccine with the cellular vaccine (Vaxicoq degrees ) marketed in France (combined with diphtheria and tetanus valencies) suggest that clinical protection is slightly lower after primary vaccination with the two acellular vaccines. "
06/01/1998 - "Recipients of acellular vaccines developed higher anti-FHA concentrations and more rapid anti-PT serological responses that infants who received whole cell pertussis vaccine combined with diphtheria and tetanus toxoids (DPT). "
4. Diphtheria
03/01/1992 - "Whereas control of pertussis in the United States may be further improved through increased levels of diphtheria-tetanus-pertussis vaccination among eligible infants and children, the use of acellular vaccines in adolescents and adults may also be needed to reduce the burden of pertussis in very young infants."
12/01/2005 - "Acellular vaccines against diphtheria-tetanus-pertussis (acellular pertussis) (DTaP) are being progressively introduced into vaccination programs worldwide, with the aim of reducing T-helper 1 (Th1)-associated reactogenicity associated with the cellular diphtheria-tetanus-pertussis (whole-cell pertussis) (DTwP) vaccine. "
02/01/2000 - " (5) In the absence of direct comparisons with the cellular pertussis vaccine available in France in tetravalent or pentavalent vaccines, indirect evidence and data from a trial comparing the acellular two-component vaccine with the cellular vaccine (Vaxicoq degrees ) marketed in France (combined with diphtheria and tetanus valencies) suggest that clinical protection is slightly lower after primary vaccination with the two acellular vaccines. "
06/01/1998 - "Recipients of acellular vaccines developed higher anti-FHA concentrations and more rapid anti-PT serological responses that infants who received whole cell pertussis vaccine combined with diphtheria and tetanus toxoids (DPT). "
03/01/1996 - "Immunogenicity of the acellular vaccines, persistence of antibodies and adverse reactions were compared with those achieved with a whole-cell diphtheria-pertussis-tetanus (DPT) vaccine. "
5. Rubella (German Measles)

Related Drugs and Biologics

1. Vaccines
2. Antibodies
3. Antigens
4. Pertussis Toxin
5. pertactin
6. Hemagglutinins (Hemagglutinin)
7. Diphtheria-Tetanus-Pertussis Vaccine (DPT Vaccine)
8. Pertussis Vaccine
9. Diphtheria-Tetanus-acellular Pertussis Vaccines (Tripedia)
10. Virulence Factors (Pathogenicity Factors)

Related Therapies and Procedures

1. Injections